These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8037915

  • 21. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
    Ciancio G, Burke GW, Suzart K, Roth D, Kupin W, Rosen A, Olson L, Esquenazi V, Miller J.
    Transplantation; 2002 Apr 15; 73(7):1100-6. PubMed ID: 11965039
    [Abstract] [Full Text] [Related]

  • 22. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 23. The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases.
    Yan H, Tan X, Yu J, Liang T, Shi W, Li L, Peng C.
    Int Ophthalmol; 2022 Jul 15; 42(7):2175-2184. PubMed ID: 35048245
    [Abstract] [Full Text] [Related]

  • 24. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection.
    Tsai MK, Chueh SC, Hu RH, Lee PH.
    J Formos Med Assoc; 2003 Feb 15; 102(2):91-6. PubMed ID: 12709737
    [Abstract] [Full Text] [Related]

  • 25. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
    Montero N, Webster AC, Royuela A, Zamora J, Crespo Barrio M, Pascual J.
    Cochrane Database Syst Rev; 2014 Sep 15; 2014(9):CD007669. PubMed ID: 25220222
    [Abstract] [Full Text] [Related]

  • 26. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.
    Gheith OA, Nematalla AH, Bakr MA, Refaie A, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2011 Apr 15; 9(2):121-7. PubMed ID: 21453230
    [Abstract] [Full Text] [Related]

  • 27. [Ophthalmologic effects of corticotherapy in kidney diseases treated by dialysis and kidney transplantation].
    Rousselie F, Fontaine M, Wassermann-Thomine A.
    Bull Mem Soc Fr Ophtalmol; 1976 Apr 15; (87):58-62. PubMed ID: 773462
    [No Abstract] [Full Text] [Related]

  • 28. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
    Ciancio G, Burke GW, Gaynor JJ, Carreno MR, Cirocco RE, Mathew JM, Mattiazzi A, Cordovilla T, Roth D, Kupin W, Rosen A, Esquenazi V, Tzakis AG, Miller J.
    Transplantation; 2005 Aug 27; 80(4):457-65. PubMed ID: 16123718
    [Abstract] [Full Text] [Related]

  • 29. Steroid withdrawal based on lymphocyte sensitivity to endogenous steroid in renal transplant recipients.
    Takeuchi H, Matsuno N, Hirano T, Gulimire M, Hama K, Nakamura Y, Iwamoto H, Toraishi T, Kawaguchi T, Okuyama K, Unezaki S, Nagao T.
    Biol Pharm Bull; 2011 Aug 27; 34(10):1578-83. PubMed ID: 21963498
    [Abstract] [Full Text] [Related]

  • 30. Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy.
    Sandrini S, Setti G, Bossini N, Maffei C, Iovinella L, Tognazzi N, Maffeis R, Nodari F, Portolani N, Cancarini G.
    Clin Transplant; 2009 Aug 27; 23(1):16-22. PubMed ID: 18727661
    [Abstract] [Full Text] [Related]

  • 31. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
    Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DK.
    Clin Transplant; 1995 Aug 27; 9(4):334-9. PubMed ID: 7579743
    [Abstract] [Full Text] [Related]

  • 32. Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head.
    Shibatani M, Fujioka M, Arai Y, Takahashi K, Ueshima K, Okamoto M, Yoshimura N, Hirota Y, Fukushima W, Kubo T.
    Acta Orthop; 2008 Oct 27; 79(5):631-6. PubMed ID: 18839369
    [Abstract] [Full Text] [Related]

  • 33. [Clinical effect of induction therapy with monoclonal antibodies after deceased-donor kidney transplantation (an experience from Vilnius Center)].
    Rainiene T, Dobrovolskiene R, Dainys B, Kucinskis G, Zelvys A.
    Medicina (Kaunas); 2007 Oct 27; 43 Suppl 1():109-13. PubMed ID: 17551287
    [Abstract] [Full Text] [Related]

  • 34. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate.
    Tanriover B, Jaikaransingh V, MacConmara MP, Parekh JR, Levea SL, Ariyamuthu VK, Zhang S, Gao A, Ayvaci MUS, Sandikci B, Rajora N, Ahmed V, Lu CY, Mohan S, Vazquez MA.
    Clin J Am Soc Nephrol; 2016 Sep 07; 11(9):1650-1661. PubMed ID: 27364616
    [Abstract] [Full Text] [Related]

  • 35. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP.
    Lancet; 1997 Oct 25; 350(9086):1193-8. PubMed ID: 9652559
    [Abstract] [Full Text] [Related]

  • 36. Steroid-induced glaucoma and cataract in renal transplant recipients.
    Ticho U, Durst A, Licht A, Berkowitz S.
    Isr J Med Sci; 1977 Sep 25; 13(9):871-4. PubMed ID: 336581
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO, Price FW.
    Ophthalmology; 2006 Oct 25; 113(10):1785-90. PubMed ID: 16884779
    [Abstract] [Full Text] [Related]

  • 38. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.
    Boots JM, Christiaans MH, Van Duijnhoven EM, Van Suylen RJ, Van Hooff JP.
    Transplantation; 2002 Dec 27; 74(12):1703-9. PubMed ID: 12499885
    [Abstract] [Full Text] [Related]

  • 39. Hypothalamic-pituitary-adrenocortical suppression and recovery in renal transplant patients returning to maintenance dialysis.
    Rodger RS, Watson MJ, Sellars L, Wilkinson R, Ward MK, Kerr DN.
    Q J Med; 1986 Nov 27; 61(235):1039-46. PubMed ID: 3310063
    [Abstract] [Full Text] [Related]

  • 40. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B, John U, Plank C, Wühl E, Weber LT, Misselwitz J, Rascher W, Mehls O, Tönshoff B.
    Transplantation; 2004 Jul 27; 78(2):228-34. PubMed ID: 15280683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.